Russian Journal of Skin and Venereal DiseasesRussian Journal of Skin and Venereal DiseasesРоссийский журнал кожных и венерических болезней1560-95882412-9097Eco-Vector3675110.17816/dv36751ArticlesСтатьиResearch ArticleTHE ROLE OF LL-37 ANTIBACTERIAL PEPTIDE IN THE PATHOGENESIS OF PSORIASISРоль антимикробного пептида LL-37 в патогенезе псориазаPineginB. VПинегинБ. В.

д-р мед. наук, проф.

bvpinegin@yandex.ruФГБУ Государственный научный центр Институт иммунологии ФМБА России15102012155NO5 (2012)№5 (2012)323721072020Copyright ©; 2012, Eco-VectorCopyright ©; 2012, ООО "Эко-Вектор"2012Eco-VectorООО "Эко-Вектор"https://rjsvd.com/1560-9588/article/view/36751

Published data on the role of LL-37 antibacterial peptide in initiation and inhibition of psoriatic inflammation are reviewed and probable approaches to its therapeutic use are discussed.

Представлен анализ данных литературы о роли антимикробного пептида LL-37 в инициации и ингибиции псориатического воспаления. Рассмотрены возможные пути его терапевтического применения.

psoriasisimmune system cellscytokinesLL-37 peptideпсориазклетки иммунной системыцитокиныпептид LL-37Lee P.H., Ohtake T., Zaiou M., Murakami M., Rudisill J.A., Lin K.H., Gallo R.L. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. U S A. 2005; 102(10): 3750—5.Будихина А.С., Макаров Е.А., Пинегин Б.В. Применение проточной цитометрии для оценки противомикробной активности кателицидина LL-37. Иммунология 2011; 32(1): 35—7.Кулаков В.В., Макаров Е.А., Пащенков М.В., Климова С.В., Пинегин Б.В. Цитотоксический эффект пептида LL-37 на перевиваемые миело- и лимфобластоидные клетки человека. Иммунология 2011; 32(2): 75—7.Morizane S., Yamasaki K., Mühleisen B., Kotol P.F., Murakami M., Aoyama Y., et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J. Invest. Dermatol. 2012; 132(1): 135—143. doi: 10.1038/ jid.2011.259.Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449(7162): 564—9.Bianchi M.E. DAMPs, PAMTs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007; 81(1): 1—5.Dorschner R.A., Pestoniamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., et al. Cutaneous кушу induces the release of cathelicidin antimicrobial peptides active against group A Steptococcus. J. Invest. Dermatol. 2001; 117(1): 91—7.Heilborn J.D., Nilsson M.F., Kratz G., Weber G., Sorensen O., Borregaard N., Ståhle-Bäckdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 2003; 120(3): 379—89.Sandgren S., Wittrup A., Cheng F., Jönsson M., Eklund E., Busch S., Belting M. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid in nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 2004; 279(17): 17951—6.Hurtado P., Peh C.A. LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells. J. Immunol. 2010; 184(3): 1425—35.Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 2005; 202(1): 135—43.Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 2009; 206(9): 1983—94.Guiducci C., Ott G., Chan J.H., Damon E., Calacsan C., Matray T., et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 2006; 203(8): 1999—2008.Hasan M., Ruksznis C., Wang Y., Leifer C.A. Antimicrobial peptides inhibit polyinosinic-polycytidilic acid-induced immune responses. J. Immunol. 2011: 187(11): 5653—9.Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N. Engl. J. Med. 2009; 361(5): 496—509.Shepherd J., Little M.C., Nicklin M.J. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J. Invest. Dermatol. 2004; 122(3): 665—9.Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Inteleukin 1beta and 6 but not transforming growth factorbeta are essential for the differentiation of interleukin 17-produc-ing human T helper cells. Nat. Immunol. 2007; 8(9): 942—9.Johansen C., Moeller K., Kragballe K., Iversen L. The activity of caspase-1 is increased in lesional psoriatic epidermis. J. Invest. Dermatol. 2007; 127(12): 2857—64.Feldmeyer L., Keller M., Niklaus G., Hohl D., Werner S., Beer H.D. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Сшт. Biol. 2007: 17(13): 1140—5.Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDN and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458(7237): 514—8.Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458(7237): 509—13.Dombrowski Y., Peric M., Koglin S., Kammerbauer C., Göss C., Anz D., et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci. Transl. Med. 2011; 3(82): 82ra38Li X.B., Zhang Z.R., Schluesener H.J., Xu S.Q. Role of exosomes in immune regulation. J. Cell Mol. Med. 2006; 10(2): 364—75.Miller L.S., Sørensen O.E., Liu P.T., Jalian H.R., Eshtiaghpour D., Behmanesh B.E., et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 2005; 174(10): 6137—43.Chamorro C.I., Weber G., Grönberg A., Pivarcsi A., Ståhle M. The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J. Invest. Dermatol. 2009; 129(4): 937—44.Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., Agerberth B. Conformation-dependent antibacterial activity o the naturally occurring human peptide LL-37. J. Biol. Chem. 1998; 273(6): 3718—24.Wang Y., Agerberth B., Löthgren A., Almstedt A., Johansson J. Apolipoprotein A-1 binds and inhibits the antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 1998; 273(50): 33115—8.Schauber J., Dombrowski Y., Besch R. Pathogenic DNA. Cytsolic DNA promotes inflammation in psoriasis. Cell Cycle 2011; 10(18): 3038—9.Peric M., Koglin S., Dombrowski Y., Gross K., Bradac E., Büchau A., et al. Vitamin D analog differentially control antimicrobial peptide «alarmin» expression in psoriasis. PloS One 2009; 4(7): e6340.Vähävihu K., Ala-Houhala M., Peric M., Karisola P., Kautiainen H., Hasan T., et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br. J. Dermatol. 2010; 163(2): 321—8.Albanesi C.C., Scarponi S., Pallotta R., Daniele R., Bosisio D., Madonna S., et al. Chemerin expression marks early psoriasis skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 2009; 206(1): 249—58.Wolk K., Haugen H.S., Xu W., Witte E., Waggie K., Anderson M., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not. J. Mol. Med. (Berl). 2009; 87(5): 523—36.Ramgolam V.S., Sha Y., Jin J., Zhang X., Markovic-Plese S. IFN-β inhibits human Th17 cell differentiation. J. Immunol. 2009; 183(8): 5418—27.